Journals / Türk Pediatri Arşivi / 2020 / Cilt: 55 - Sayı: 3

Evaluation of clinical, neuroradiologic, and genotypicfeatures of patients with L-2-hydroxyglutaric aciduria

L-2-hidroksiglutarik asidüri hastalarında klinik, nöroradyolojik ve genetik bulguların değerlendirilmesi

Pages
290–298
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In patients with L-2-hydroxyglutaric aciduria, incipient headache, tinnitus, altered consciousness, and seizures can be indicative of brain tumors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: L-2-hydroxyglutaric aciduria is a slowly progressive neurometabolic disorder caused by an enzymatic deficiency of L-2-hydroxyglutarate dehydrogenase.
📊
Key Findings & Data:Here, we aimed to evaluate the clinical, neuroradiologic, and genotypic characteristics of patients with L-2-hydroxyglutaric aciduria who were followed in our outpatient clinic.Material and Methods: Twenty-five patients with L-2-hydroxyglutaric aciduria were enrolled in the study.
💡
Conclusion & Impact:In patients with L-2-hydroxyglutaric aciduria, incipient headache, tinnitus, altered consciousness, and seizures can be indicative of brain tumors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: L-2-hydroxyglutaric aciduria is a slowly progressive neurometabolic disorder caused by an enzymatic deficiency of L-2-hydroxyglutarate dehydrogenase. Here, we aimed to evaluate the clinical, neuroradiologic, and genotypic characteristics of patients with L-2-hydroxyglutaric aciduria who were followed in our outpatient clinic.Material and Methods: Twenty-five patients with L-2-hydroxyglutaric aciduria were enrolled in the study. Data regarding demographic, clinical, and neuroradiologic findings and molecular analysis were evaluated retrospectively.Results: The mean age of patients at the time of diagnosis was 12.09±8.02 years, whereas the mean age at the time of the first symptoms was 39.47±29.96 months. Diagnostic delay was found as 9.95±7.78 years. Developmental delay, decrease in school success, and seizures were the most common initial symptoms; however, behavioral problems and seizures became more prominent in the disease course. At the time of diagnosis, mental retardation and at least one pathologic cerebellar finding were detected in all symptomatic patients. Three patients developed brain tumors. The most common neuroimaging findings were subcortical white matter changes and cerebellar dentate nucleus involvement. In one patient, there was only isolated basal ganglia involvement without white matter lesions. Patients with similar genotypic features exhibited different clinical and radiologic findings.Conclusion: Although clinical symptoms appear early in L-2-hydroxyglutaric aciduria, there is approximately a ten-year delay in diagnosis. In subjects in whom brain tumor is detected in early childhood, L-2-hydroxyglutaric aciduria should be considered in the differential diagnosis in the presence of mental retardation accompanied by developmental delay, cerebellar and pyramidal findings, and behavior disorders in a wide spectrum ranging from autism spectrum disorder to psychosis. In patients with L-2-hydroxyglutaric aciduria, incipient headache, tinnitus, altered consciousness, and seizures can be indicative of brain tumors.

Özet

Amaç: L-2-hidroksiglutarik asidüri; L-2-hidroksiglutarat dehidrogenazenzimindeki yetersizlik sonucu gelişen, yavaş seyirli bir nörometabolik hastalıktır. Çalışmamızda kliniğimizde izlenen L-2-hidroksiglutarikasidüri olgularının, klinik, nöroradyolojik ve genotipik özelliklerinin tanımlanması amaçlanmıştır. Gereç ve Yöntemler: Çalışmaya L-2-hidroksiglutarik asidüri tanılı 25olgu alındı. Olgulara ait demografik veriler, klinik belirti ve bulgular,görüntüleme bulguları ile genetik analiz sonuçları geriye dönük değerlendirildi. Bulgular: Olguların ortalama tanı yaşı 12,09±8,02 idi. İlk yakınmaları ortalama 39,47±29,96 ayda başlamıştı ve ortalama 9,95±7,78 yıllık tanısal gecikme saptandı. Gelişimsel gerilik, okul başarısında azalma ve nöbetleren sık görülen ilk başvuru yakınmaları iken hastalığın seyrinde davranışsorunları ve nöbetlerin öne çıktığı görüldü. Belirtili olguların tümünde,tanı anında zekâ geriliği ve en az bir patolojik serebellar fizik bakı bulgusu saptandı. Üç olguda beyin tümörü gelişti. Subkortikal ak maddedeğişiklikleri ile serebellar dentat nükleus tutulumu en sık görülen görüntüleme bulgularıydı. Bir olguda ak madde tutulumu olmayıp, izolebazal gangliyon tutulumu vardı. Benzer genotipik özelliklere sahip olanolgular, farklı klinik ve radyolojik bulgulara sahipti. Çıkarımlar: Klinik bulguların erken yaşlarda ortaya çıkmasına karşın,L-2-hidroksiglutarik asidüri olgularında ortalama 10 yıllık tanısal gecikme yaşanmaktadır. Erken yaşta beyin tümörü saptanan olgularda, zekâgeriliğine eşlik eden gelişimsel gecikme, serebellar ya/ya da piramidalbulguların varlığında ve otizm spektrumu bozukluğundan psikoza uzanan geniş spektrumdaki davranış bulgularının varlığında L-2-hidrok siglutarik asidüri ayırıcı tanıda akılda tutulmalıdır. Tanılı olgularda yenibaşlayan baş ağrısı, kulak çınlaması, bilinç düzeyi değişikliği ve karakterdeğiştiren nöbet, malignite gelişimi açısından uyarıcı olmalıdır. Özgülnöroradyolojik bulguların tanınması, olguların daha erken tanı almasınısağlayabilir.

🔖

Cite This Article

YALÇINKAYA, C., KIYKIM, E., ZÜBARİOĞLU, T., ZEYBEK, Ç. A., CANSEVER, M. Ş., YEŞİL, G., ORUÇ, Ç., GEZDİRİCİ, A., ENVER, E. Ö. (2022). Evaluation of clinical, neuroradiologic, and genotypicfeatures of patients with L-2-hydroxyglutaric aciduria. Türk Pediatri Arşivi, Cilt: 55 - Sayı: 3, 290–298. https://ajindex.com/articles/640942

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Van Schaftingen E, Rzem R, Veiga-da-Cunha M. L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair. J Inherit Metab Dis 2009; 32: 135–42.
  2. Kranendijk M, Struys EA, Salomons GS, Van der Knaap MS, Jakobs C. Progress in understanding 2-hydroxyglutaric acidurias. J Inherit Metab Dis 2012; 35: 571–87.
  3. Hoffmann GF, Kölker S. Cerebral organic acid disorders and other disorders of lysine catabolism. In: Saudubray JM, Baumgartner MR, Walter. J, editors. Inborn Metabolic Diseases: Diagnosis and Treatment. 6th edition. Springer Verlag, Heidelberg; 2016.p.333–48.
  4. Patay Z, Mills JC, Löbel U, Lambert A, Sablauer A, Ellison DW. Cerebral neoplasms in L-2 hydroxyglutaric aciduria: 3 new cases and meta-analysis of literature data. AJNR Am J Neuroradiol 2012; 33: 940–43.
  5. Steenweg ME, Salomons GS, Yapici Z, et al. L-2-Hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients. Radiology 2009; 251: 856–65.
  6. Fourati H, Ellouze E, Ahmadi M, et al. MRI features in 17 patients with l2 hydroxyglutaric aciduria. Eur J Radiol Open 2016; 3: 245–50.
  7. Steenweg ME, Jakobs C, Errami A, et al. An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study. Hum Mutat 2010; 31: 380–90.
  8. Samuraki M, Komai K, Hasegawa Y, et al. A successfully treated adult patient with L-2-hydroxyglutaric aciduria. Neurology 2008; 70: 1051–2. Yilmaz K. Riboflavin treatment in a case with l-2-hydroxyglutaric aciduria. Eur J Paediatr Neurol 2009; 13: 57–60.
  9. Faiyaz-Ul-Haque M, Al-Sayed MD, Faqeih E, et al. Clinical, neuroimaging, and genetic features of L-2-hydroxyglutaric aciduria in Arab kindreds. Ann Saudi Med 2014; 34: 107–14.
  10. Canda E, Köse M, Yazıcı H, et al. Clinical, Neuroimaging, and Genetic Features of the Patients with L-2-Hydroxyglutaric Aciduria. J Pediatr Res 2018; 5: 39–43.
  11. Topçu M, Aydin OF, Yalçinkaya C, et al. L-2-hydroxyglutaric aciduria: a report of 29 patients. Turk J Pediatr 2005; 47:1–7.
  12. Zafeiriou DI, Ververi A, Salomons GS, et al. L-2-Hydroxyglutaric aciduria presenting with severe autistic features. Brain Dev 2008; 30: 305–7.
  13. Kiykim E, Zeybek CA, Zubarioglu T, et al. Inherited metabolic disorders in Turkish patients with autism spectrum disorders. Autism Res 2016; 9: 217–23.
  14. Haliloglu G, Jobard F, Oguz KK, et al. L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings. Neuropediatrics 2008; 39: 119–22.
  15. Rogers RE, Deberardinis RJ, Klesse LJ, Boriack RL, Margraf LR, Rakh